Tags: Drug.

Plicamycin (INN also known as mithramycin; trade name Mithracin) is an antineoplastic antibiotic produced by Streptomyces plicatus. It is an RNA synthesis inhibitor. The manufacturer discontinued production in 2000.

Plicamycin.svg
ATC prefix
L01
ATC suffix
DC02
CAS number
18378-89-7
DrugBank
DB06810
FDA UNII code
NIJ123W41V
IUPAC name
(1S)-5-deoxy-1-C-((2S3S)-7-[26-dideoxy-3-O-(26-dideoxy-β-(D)-arabino-hexopyranosyl)-β-(D)-arabino-hexopyranosyl]oxy-3-[26-dideoxy-3-C-methyl-β-(D)-ribo-hexopyranosyl-(1→3)-26-dideoxy-β-(D)-arabino-hexopyranosyl-(1→3)-26-dideoxy-β-(D)-arabino-hexopyranosyl]oxy-510-dihydroxy-6-methyl-4-oxo-1234-tetrahydroanthracen-2-yl)-1-O-methyl-(D)-xylulose
PubChem
5284610

Loading...

This page contains content from the copyrighted Wikipedia article "Plicamycin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.